Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Quin-Dalf-Quinupristin-Dalfopristin, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
HUP Inpatients, Jan-Dec 2008, Blood Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Eryth	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	188	10	44	49	30	97	46	96	47	93	100	100	100
Coagulase negative staphylococci	168	5	25	45**	25	57	25	nt	27	81	100	100	100
Enterococcus sp	184	29	R+	nt	nt	nt*	nt	R+	22	51	96	66	31
*high level gentamicin data not available for technical reasons
**CNS not routinely tested for inducible clinidamycin resistance,  susceptibily may be higher
+, R wild type resistance, not tested
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	130	42	nt*	77	87	88	90	89	99	66	55(85)	61	100
E. cloacae	23	0	0	0	70	79	96	96	100	92	70(83)	87	100
K. pneumoniae	80	0	64	75	80	82	87	84	90	79	0(75)	77	90
K. oxytoca	13	0	77	92	92	92	100	92	100	100	0(92)	92	100
P. mirabilis	12	92	92	92	100	100	100	100	100	77	100(100)	85	100
P. aeruginosa	61	R+	R+	R+	92	90	93	94	97	62	90	R+	76
S. marcescens	23	0	0	0	87	96	91	94	94	96	93(96)	100	96
* could not be tested for technical reasons
+, R wild type resistance, not tested
HUP Inpatients, Jan-Dec 2008, Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	725	8	47	60	36	97	47	97	57	96	100	100	100
Coagulase negative staphylococci	37	5	24	51*	41	62	24	nt	38	92	100	100	100
Enterococcus sp	262	53	R+	R+	nt	nt**	nt	R+	38	42	95	42	61
*CNS not tested for inducible clindamycin resistance, susceptibility may be higher
+, R wild type resistance, not tested
**high level gentamicin data not available for technical reasons
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero (Imip)	Pip (Pip/Tazo)	Tmp/Sxt
A. baumanii	35	0	96	0	36	46	75	75	nt	50	14(75)	0(0)	54
C. freundii	22	0	0	0	70	86	57	70	100	72	100	36(36)	43
C. koseri	19	0	0	90	100	100	100	100	100	100	100	0(0)	95
Pantoea (Enterobacter) aerogenes	29	0	0	0	83	93	100	100	100	97	100	79(83)	93
E. cloacae	100	0	0	0	73	87	90	96	98	89	99	71(78)	83
E. coli	239	34	nt*	74	88	89	86	87	98	64	98	52(88)	69
K. pneumoniae	196	0	58	65	68	68	76	67	76	67	75	0(65)	64
K. oxytoca	28	0	86	60	100	100	100	100	100	100	100	0(93)	100
P. mirabilis	70	89	92	94	98	96	95	97	100	80	100	96(98)	85
P. aeruginosa	461	R+	R+	R+	78	76	77	92	87	58	73	76	R+
Steno. maltophila	34	R+	R+	R+	R+	R+	3	R+	R+	nt	R+	R+	100
S, marcescens	57	0	0	0	97	100	98	87	98	98	100	86(90)	100
+, R wild type resistance, not tested
* could not be tested for technical reasons
HUP Inpatients, Jan-Dec 2008, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Ery	Clinda	Gent	Naf	Nitro	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	69	10	34	22	36	97	34	100	94	30	93	100	100	100
Coagulase negative staphylococci	222	4	28	29	58**	78	28	99	nt	28	nt	100	99	100
Enterococcus sp	651	62	R+	nt	nt	nt	nt	63	R+	43	34	97	39	64
**CNS not routinely tested for inducible clindamycin resistance, susceptibility may be higher
+, R wild type resistance, not tested
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefp	Gent	Tobra	Amik	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
C. koseri	27	0	96	100	100	nt	100	100	nt	100	100	78	nt	100	76	nt
C. freundii	24	0	8	0	88	nt	92	92	nt	88	88	92	nt	76	64	nt
Pantoea (Enterobacter) aerogenes	29	0	0	0	93	nt	100	100	nt	96	97	17	nt	97	93	nt
E. cloacae	57	0	0	0	65	nt	79	83	nt	84	86	21	nt	74	78	nt
E. coli	894	34	78	88	97	nt	91	92	nt	71	72	95	nt	74	74	nt
K. pneumoniae	341	0	74	71	74	nt	80	75	nt	75	72	27	nt	70	75	nt
K. oxytoca	26	0	81	54	96	nt	77	85	nt	77	77	69	nt	81	77	nt
M. morganii	13	0	7	8	100	nt	100	100	nt	77	77	8	nt	85	77	nt
P. mirabilis	100	82	94	86	98	nt	91	99	nt	75	75	0	nt	78	0	nt
P. aeruginosa	179	R+	R+	R+	92	90	78	85	90	67	nt	nt	90	R+	nt	85
+, R wild type resistance, not tested